Metabolically dysfunction associated steatohepatitis (MASH) is entering a new phase of clinical management with the introduction of disease-modifying therapies such as resmetirom. This CME/CE video expert exchange focuses on translating emerging therapeutic advances into practical strategies for monitoring treatment success in clinical practice. Faculty will discuss how to identify appropriate candidates for therapy, implement guideline-aligned follow-up at key intervals, and integrate noninvasive tools such as FIB-4, VCTE, MRI-PDFF, and multi-biomarker panels into structured monitoring algorithms. The program also addresses challenges in interpreting discordant test results, coordinating care between physicians and advanced practice providers, and maintaining consistent follow-up in busy clinical settings. Through case-based discussions and evidence-informed guidance, participants will learn to evaluate treatment response, optimize therapeutic decisions, and strengthen team-based care to improve long-term outcomes for patients with MASH at risk of disease progression.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 50 Division Street
Pricing
CME included with membership
| Free CME Activity | Free |
Collected from the provider’s public pages · source
Specialties served/covered
- Clinical Informatics
- Dermatology
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Medical Leadership & Administration
- Medical Oncology
- Neonatal-Perinatal Medicine
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Pediatric Neurology
- Sleep Medicine
- Surgical Oncology
- Urological Oncology
- Vascular Neurology
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Case-based learning
- includes On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedFeb 23, 2026
-
Last day to claim creditFeb 24, 2027 5 months left
-
Medscape, LLC Managing Metabolic Dysfunction-Associated Steatohepatitis in Practice: A Virtual Patient Simulation Exercise
-
Learner’s Digest International (TM) Drug Development for Metabolic Dysfunction-Associated Steatohepatitis/Management of Refractory Hepatic Encephalopathy
-
PRIME Education, Inc. (PRIME®) Keeping Pace in a New Era of MASH: Navigating the Latest Treatment Guidance and Novel Therapies
